https://www.selleckchem.com/pr....oducts/mg-101-alln.h
Increasing distance from residence to treatment facility was an unadjusted predictor for undergoing primary RPLND (p 0.001). Median follow-up was 54 months and there was no significant difference in overall survival between CS I teratoma patients managed with RPLND and those managed with surveillance (p = 0.13). There has been a trend toward increasing adoption of surveillance for the management of early stage pure testicular teratoma in adults. Our findings suggest that surveillance provides comparable survival outcomes to pri
Like
Comment
Share
